Jim Cramer Says This Stock Is ‘Too Risky’
On CNBC’s "Mad Money Lightning Round," Jim Cramer said he likes Cadre Holdings Inc (NYSE: CDRE) as it "makes things, does stuff, sells at a profit, gives you money back."
The Daily Biotech Pulse: FDA Wants Omicron-Targeted COVID-19 Boosters, Provention Bio Clears Hits Hurdle For Diabetes Prevention Drug, Oxford Biomedica, AstraZeneca Strike Vaccine Pact
Here's a roundup of top developments in the biotech space over the last 24 hours:
Wolverine Worldwide Sells Champion Trademarks To HanesBrands For $90M Cash
Wolverine World Wide Inc (NYSE:WWW) subsidiary, Keds LLC, has sold Champion trademarks for footwear in the U.S. and Canada to its…
Amplitude Named Thomas Hansen as Company’s First President
Amplitude, Inc. (Nasdaq: AMPL), the pioneer in digital optimization, today announced the appointment of Thomas Hansen as its first President.
Oxford Biomedica Inks New Three Year Deal To Make AstraZeneca’s COVID-19 Vaccine
Oxford Biomedica plc (OTC:OXBDF) signed a new three-year agreement to potentially make AstraZeneca Plc’s (NASDAQ:AZN) COVID-19 vaccine beyond 2022. The new agreement represents…
U.S. Stock Futures Edge Lower Ahead Of Manufacturing Data
Pre-open movers
U.S. stock futures traded slightly lower in early pre-market trade on Friday after the Wall Street recorded its worst first half in over 50 years.
Attention Biotech Investors: Mark Your Calendar For These July PDUFA Dates
The biotech sector is poised to end June on a positive note, despite largely disappointing regulatory decisions scheduled during the month, thanks to a reversal in broader market sentiment.
Akerna Shares Dip 53%, Here’s 78 Biggest Movers From Yesterday
Gainers
Revelation Biosciences, Inc. (NASDAQ: REVB) surged 77.4% to close at $1.11 on Thursday after jumping 27% on Wednesday. Revelation Biosciences recently announced completion of dosing for Phase 1b CLEAR clinical study of REVTx-99b for the treatment of allergic rhinitis.
eToro Said To Abandon SPAC Merger
Retail stock and cryptocurrency brokerage platform eToro is reportedly not going ahead with its planned blank-check merger.
Micron, Akebia Therapeutics And 3 Stocks To Watch Heading Into Friday
Some of the stocks that may grab investor focus today are: